Chengda Biology establishes a new pharmaceutical technology company in Shanghai

Mars Finance News: The AiQiCha app shows that recently, Shanghai Chengda Zhiyuan Medical Technology Co., Ltd. was established, with Li Yeji as the legal representative, a registered capital of 1 billion RMB, and business scope including artificial intelligence theory and algorithm software development, basic artificial intelligence software development, artificial intelligence application software development, artificial intelligence innovation and entrepreneurship service platform, etc. Shareholder information indicates that the company is wholly owned by Liaoning Chengda Biological Co., Ltd.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin